Bizarre Patents
A coffin, for allowing inclination for display of a deceased person in a natural position.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6534532 | Carbanilides as pesticides The invention concerns novel carbanilides of formula (I), ##STR1## in which A, Q, R, X, Z and m have the meanings given in the description. The invention further concerns a plurality of processes for preparing these substances, in their use as microbiocid... | 03/18/2003 |
| 6528528 | Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis The present invention provides compounds of Formula I shown below. ##STR1## The present invention also provides methods of treating or preventing 3 inflammation or atherosclerosis, and a pharmaceutical composition that contains a compound of Formula I.... | 03/04/2003 |
| 6525086 | Compounds, their preparation and use The present invention relates to compounds of formula (I) ##STR1## wherein R1, R2, R3, R4, R5, R6, R7, R8, A, X, T, Q, Z, U, Y, Ar, p and n are as defined in the speci... | 02/25/2003 |
| 6518290 | Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators A compound of formula (I) and pharmaceutically acceptable salts, solvates and hydrolysable esters thereof ##STR1## wherein; X1 represents O or S; R1 and R2 independently represent H, halogen, --CH3 and --OCH | 02/11/2003 |
| 6514955 | Multi-faceted method to repress reproduction of latent viruses in humans and animals Disclosed are methods for repressing reproduction of latent viruses, such as HIV, in animals by the generally concurrent administration of (1) antioxidants including a glutathione agent; and (2) an NFKB induction inhibitor. Also disclosed are pharmaceutic... | 02/04/2003 |
| 6511670 | (poly)thiaalkynoic compounds and pharmaceutical/cosmetic compositions comprised thereof Novel pharmaceutically/cosmetically-active (poly)thiaalkynoic compounds have the structural formula (I): R1 --Y--CH2 --C.ident.C--CH2 --S--CH2 --R2 (I) and are useful for the treatment of a wide variety of dis... | 01/28/2003 |
| 6511999 | Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2 antagonists The present invention provides novel compounds represented by the general formula I. ##STR1## wherein m, n, X, Y, Z, R, R1 and R2 are as defined in the specification or a pharmaceutically acceptable salt thereof. The novel compo... | 01/28/2003 |
| 6511981 | Compositions and treatment for diabetic complications This invention is directed to methods, pharmaceutical compositions and kits comprising an aldose reductase inhibitor (ARI), a prodrug thereof or a pharmaceutically acceptable salt of said ARI or said prodrug and a selective COX-2 inhibitor, a prodrug ther... | 01/28/2003 |
| 6509379 | Phenylacetic acid derivatives, process and intermediate products for their preparation, and their use as fungicides and pesticides Phenylacetic acid derivatives of the formula I ##STR1## where the variables are as disclosed herein, their salts, processes and intermediates for their preparation, and their use for controlling harmful fungi and animal pests.... | 01/21/2003 |
| 6509364 | Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2 antagonists The present invention provides novel compounds represented by the general formula I. ##STR1## and pharmaceutically acceptable salts thereof wherein m, n, X, R, R1 and R2 are as defined in the specification. The novel compounds are ... | 01/21/2003 |
| 6509348 | Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination A method is provided for inhibiting platelet aggregation and thrombus formation by administering to a patient an ADP-receptor blocking antiplatelet drug, such as clopidogrel, in combination with a thromboxane A2 receptor antagonist, such as ife... | 01/21/2003 |
| 6506781 | Oxazole PPAR antagonist A method is disclosed for rational design of a PPAR, FXR, LXR-alpha, or LXR-beta antagonist comprising chemical modification of a PPAR, FXR, LXR-alpha, or LXR-beta agonist to: a) prevent formation of a hydrogen bond between the agonist and tyrosine or his... | 01/14/2003 |
| 6506757 | Carboxylic acid derivatives and drugs containing the same as the active ingredient A peroxisome proliferator activated receptor regulator containing a carboxylic acid derivative of formula (I) ##STR1## (wherein all symbols are as defined in the specification), a non-toxic acid thereof or a hydrate thereof as active ingredient. Because o... | 01/14/2003 |
| 6503912 | Substituted guanidine derivatives The present application relates to novel guanidine derivatives of the formula (I) ##STR1## in which R1 represents a five- or six-membered heterocyclic group; R2 represents hydrogen or alkyl, R3 represents the groupings --OR | 01/07/2003 |
| 6500849 | 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino 1,3-propanediols and related compounds Novel 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols, intermediates and processes for the preparation thereof, and methods of reducing inflammation and cell proliferation, and relieving memory dysfunction, and inhibiting bacterial and fu... | 12/31/2002 |
| 6498178 | Inhibitors of IMPDH enzyme The present invention relates to compounds which inhibit IMPDH. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibit... | 12/24/2002 |
| 6498176 | 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors ##STR1## Compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, A, D, X, Y and Z have the meaning as defined in the claims exhibit protein tyrosine kinase and protein serin/threonine kinase inhibitory activity.... | 12/24/2002 |
| 6498174 | Substituted oxazoles and thiazoles derivatives as hPPARγ and hPPAR activators The present invention discloses compounds of formula (I), and tautomeric forms, pharmaceutically acceptable salts, or solvates thereof. Preferably, the compounds of the invention are dual activators of hPPARγ and hPPAR.... | 12/24/2002 |
| 6495548 | Lactam inhibitors of matrix metalloproteinases, TNF- and aggrecanase The present application describes novel lactams and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt forms thereof, wherein ring B is a 4-8 membered lactam containing from 0-3 additional heteroatoms selected from N, O, a... | 12/17/2002 |
| 6492402 | Thrombin inhibitors The present invention relates to a compound having formula I: ##STR1## and pharmaceutically acceptable salts thereof. The compounds of formula I and pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as an... | 12/10/2002 |
| 6492396 | Substituted thioacetamides The present invention is directed to chemical compositions of substituted thioacetamides, processes for the preparation thereof and uses of the compositions in the treatment of diseases.... | 12/10/2002 |
| 6486196 | Anticancer compounds: process for their preparation and pharmaceutical compositions containing them The present invention relates to novel anticancer agents, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, and their pharmaceutically acceptable solvates. The present invention more particularly relates to novel derivatives ... | 11/26/2002 |
| 6482846 | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group and (ii) a compound that d... | 11/19/2002 |
| 6482842 | 3-aminopyrazole inhibitors of cyclin dependent kinases The present invention describes compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof. The formula I compounds are protein kinase inhibitors and are useful in the treatment of proliferative diseases, for example, cancer, inflammation an... | 11/19/2002 |
| 6482859 | Microbicidal N-sulfonylglycin alkynyloxyphenethyl amide derivatives The invention relates to novel pesticidally active compounds of the general formula I ##STR1## as well as possible isomers and mixtures of isomers thereof, wherein n is a number zero or one; and R1 is C1 -C12 alkyl that is unsu... | 11/19/2002 |
| 6472416 | Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors The present invention encompasses novel sulfonylphenylpyrazole compounds useful in the treatment of cyclooxygenase-2 mediated diseases.... | 10/29/2002 |
| 6472406 | Sulfonamidomethyl phosphonate inhibitors of beta-lactamase The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel ଲ-lactamase inhibitors, which are structurally unrelated to the nat... | 10/29/2002 |
| 6472387 | Methods of using compounds as neuro-protective agents This invention relates to novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents.... | 10/29/2002 |
| 6469060 | Compositions based on iodopropynyl-and formaldehyde donor compounds and to their use as preservatives Compositions having broad effectiveness against bacterial and fungi, which comprise (a) an iodopropynylbutyl compound and (b) one or more formaldehyde donor compounds, the formaldehyde donor compounds being N-formals, O-formals and/or a combination thereo... | 10/22/2002 |
| 6469040 | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing and treating neoplasia. In particular, the invention describes the method of preventing and treating epithelial cell neoplasia in a subject, said method ... | 10/22/2002 |
| 6469036 | Peptidyl heterocyclic ketones useful as tryptase inhibitors The present invention relates to a series of peptidyl heterocyclic ketones which are inflammatory cell serine protease inhibitors and their compositions and methods for the prevention and treatment of a variety of immunomediated inflammatory disorders. Mo... | 10/22/2002 |
| 6469032 | 3-(4'-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.... | 10/22/2002 |
| 6468555 | Pesticidal compositions Pesticidal compositions containing 4-phenoxyphenyl 2-(2-pyridyloxy)propyl ether and 2-(2,6-difluorophenyl)-4-(2-ethoxy-4-tert-butyl-phenyl)-2-oxazoline as active ingredients have excellent pesticidal efficacy.... | 10/22/2002 |
| 6465514 | Methods and compositions for the promotion of hair growth Compositions, medicaments, and methods for the promotion of hair growth are disclosed. These compositions and medicaments are comprised of either local anesthetics of the secondary or tertiary amino type and/or niacin. The preferred secondary and tertiary... | 10/15/2002 |
| 6465498 | Use of derivatives of methylene-bis-oxazolidine and compositions obtained thereby The present invention relates to stable microbicidal compositions which are characterized in that they comprise derivatives of methylenebisoxazolidine and 1H-benzimidazol-2-ylcarbamic acid. The compositions according to the invention can be employed in in... | 10/15/2002 |
| 6465428 | Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime The present invention relates to pharmaceutical combinations of group A and group B streptogramins, in particular to combinations of dalfopristine and quinupristine, with cefepime, which combinations can exhibit a synergism of antibiotic action, to pharma... | 10/15/2002 |
| 6462054 | Inhibitors of fatty acid amide hydrolase Potent inhibitors of fatty acid amide hydrolase (FAAH) are constructed having Ki 's below 200 pM and activities 102 -103 times more potent than the corresponding trifluoromethyl ketones. The potent inhibitors combine sever... | 10/08/2002 |
| 6461591 | Medical aerosol formulations A pressure-liquefied propellant mixture for aerosols, comprising a fluorinated alkane, in particular 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane, and carbon dioxide, makes possible an improvement of the wetting properties of pharmace... | 10/08/2002 |
| 6455571 | Inhibitors of neuraminidases Disclosed are compounds of the formula: ##STR1## which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caus... | 09/24/2002 |
| 6451824 | Sulfonylaminocarboxylic acids Compounds of formula (I) ##STR1## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved.... | 09/17/2002 |
